Delcath Systems

Delcath Systems R&D Expenses

The Research & Development Expenses of Delcath Systems (DCTH) as of Nov 22, 2026 is 29.25 M USD. In the previous year, Research & Development Expenses was 13.87 M USD — a change of 110.80% (higher).

R&D Expenses

29.25 MUSD

YoY

110.80%

Last updated:

Research & Development Expenses of Delcath Systems is 2025 29.25 M USD. Research & Development Expenses of Delcath Systems was 2024 13.87 M USD. It decreases by 110.80% higher compared to the previous year.

The Delcath Systems R&D Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D Expenses
Date
R&D Expenses
Jan 1, 2018
19.65 M USD
Jan 1, 2019
9.49 M USD
Jan 1, 2020
11.20 M USD
Jan 1, 2021
13.78 M USD
Jan 1, 2022
18.58 M USD
Jan 1, 2023
17.50 M USD
Jan 1, 2024
13.87 M USD
Jan 1, 2025
29.25 M USD
The Delcath Systems R&D Expenses history
YEARR&D ExpensesYoY
29.25 MUSD+110.80%
13.87 MUSD-20.73%
17.50 MUSD-5.82%
18.58 MUSD+34.87%
13.78 MUSD+23.01%
11.20 MUSD+18.03%
9.49 MUSD-51.70%
19.65 MUSD+87.23%
10.50 MUSD+24.23%
8.45 MUSD+30.25%
6.49 MUSD+50.87%
4.30 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Delcath Systems Stock analysis

What does Delcath Systems do? Delcath Systems Inc is a US-American medical technology company specializing in the development of innovative products for the treatment of various forms of liver cancer. The company was founded in 1988 in New York and is headquartered in Queensbury today. Delcath Systems is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Delcath Systems stock

Research & Development Expenses of Delcath Systems is 29.25 M USD in 2025.

Research & Development Expenses of Delcath Systems changed from 13.87 M USD to 29.25 M USD, representing a 110.80% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Research & Development Expenses Delcath Systems since 2006 – with annual values, charts, and detailed analysis.

R&D expenses represent the costs incurred in researching and developing new products, services, or processes. High R&D spending can signal innovation and future growth potential.

Research & Development Expenses's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Research & Development Expenses's Delcath Systems historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Delcath Systems

All Key Metrics — Delcath Systems